スウェーデンのオーソバイオロジクス市場見通し

◆英語タイトル:Sweden Orthobiologics Market Outlook to 2022
◆商品コード:GDMECC0233DBOD
◆発行会社(調査会社):GlobalData
◆発行日:2016年9月1日
◆ページ数:54
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:スウェーデン
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD4,995 ⇒換算¥569,430見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD9,990 ⇒換算¥1,138,860見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD14,985 ⇒換算¥1,708,290見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※レポート購入後、該当レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。



【レポートの概要】

Sweden Orthobiologics Market Outlook to 2022
Summary

GlobalData’s new report, Sweden Orthobiologics Market Outlook to 2022, provides key market data on the Sweden Orthobiologics market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market segments – Bone Graft and Substitutes, Viscosupplementation and Bone Growth Stimulators.

Note: This is an on-demand report and will be delivered within 2-3 business days of the purchase (excluding weekends)

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size for Orthobiologics market categories – Bone Graft and Substitutes, Viscosupplementation and Bone Growth Stimulators.
- Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2008 to 2015 and forecast to 2022.
- 2015 company shares and distribution shares data for Orthobiologics market.
- Global corporate-level profiles of key companies operating within the Sweden Orthobiologics market.
- Key players covered include Medtronic plc, Bioventus LLC, Sanofi, DePuy Synthes, Inc. and others.

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

【レポートの目次】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 4
2 Introduction 5
2.1 What Is This Report About? 5
2.2 Orthobiologics Market Segmentation 5
2.3 Definitions of Markets Covered in the Report 6
3 Orthobiologics Market, Sweden 7
3.1 Orthobiologics Market, Sweden, Revenue ($m), 2008-2015 7
3.2 Orthobiologics Market, Sweden, Revenue ($m), 2015-2022 9
3.2.1 Bone Grafts and Substitutes Market, Sweden, Revenue ($m), by Segment, 2008-2015 11
3.2.2 Bone Grafts and Substitutes Market, Sweden, Revenue ($m), by Segment, 2015-2022 13
3.3 Orthobiologics Market, Sweden, Volume (Units), 2008-2015 15
3.4 Orthobiologics Market, Sweden, Volume (Units), 2015-2022 17
3.4.1 Bone Grafts and Substitutes Market, Sweden, Volume (Units), by Segment, 2008-2015 19
3.4.2 Bone Grafts and Substitutes Market, Sweden, Volume (Units), by Segment, 2015-2022 21
3.5 Orthobiologics Market, Sweden, Average Price ($), 2008-2015 23
3.6 Orthobiologics Market, Sweden, Average Price ($), by Segment 2008-2015 25
3.7 Orthobiologics Market, Sweden, Distribution Share by Revenue ($m), 2008-2022 27
3.8 Orthobiologics Market, Sweden, Company Share by Revenue ($m), 2015 28
4 Overview of Key Companies in Sweden, Orthobiologics Market 30
4.1 DePuy Synthes, Inc. 30
4.1.1 Company Overview 30
4.2 Medtronic plc 30
4.2.1 Company Overview 30
4.3 Bioventus LLC 30
4.3.1 Company Overview 30
4.4 Sanofi 30
4.4.1 Company Overview 30
4.5 Seikagaku Corporation 31
4.5.1 Company Overview 31
4.6 DJO Finance LLC 31
4.6.1 Company Overview 31
4.7 Stryker Corporation 31
4.7.1 Company Overview 31
4.8 Baxter International Inc. 32
4.8.1 Company Overview 32
4.9 Anika Therapeutics, Inc. 32
4.9.1 Company Overview 32
4.10 Fidia farmaceutici S.p.A. 33
4.10.1 Company Overview 33
4.11 Ossatec Benelux B.V. 33
4.11.1 Company Overview 33
4.12 Orthofix International N.V. 33
4.12.1 Company Overview 33
4.13 Mylan N.V. 33
4.13.1 Company Overview 33
5 Orthobiologics Market Pipeline Products 35
6 Financial Deals Landscape 38
6.1 Equity Offerings 38
6.1.1 Doxa to Raise USD0.72 Million in Public Offering of Shares 38
7 Recent Developments 39
7.1 Corporate Communications 39
7.1.1 Jun 07, 2016: Corin’s Optimized Positioning System (OPS) receives 510(k) clearance 39
7.1.2 May 11, 2016: International Biophysics announces publication of new data showing Pulmonary Function Test score improvement with AffloVest airway clearance technology 39
7.1.3 Apr 26, 2016: InVivo Therapeutics Reports Conversion of a Fourth Patient Implanted with the Neuro-Spinal Scaffold in the INSPIRE Study 40
7.1.4 Dec 08, 2015: Results Of The ROC Trial Demonstrate The Benefits Of Monitoring Biotherapies 41
7.2 Financial Announcements 42
7.2.1 Oct 19, 2015: DelMar Pharmaceuticals Presents Positive Preclinical Data on VAL-083 as a Promising Treatment for Ovarian Cancer 42
7.2.2 Aug 25, 2015: Entellus Medical Surpasses 100,000 Patients Treated Worldwide 45
7.2.3 Aug 22, 2015: HealthSpot disrupts the lab industry with plans to bring 7 minute blood tests to retail pharmacy clinics 47
8 Appendix 50
8.1 Research Methodology 51
8.1.1 Coverage 51
8.1.2 Secondary Research 51
8.1.3 Primary Research 52
8.1.4 Company Share Analysis 52
8.1.5 Distribution Share Analysis 52
8.1.6 Benchmarking 52
8.2 GlobalData Consulting 53
8.3 Contact Us 53
8.4 Disclaimer 54

1.1 List of Tables
Table 1: Orthobiologics Market, Sweden, Revenue ($m), USD Constant, Historic, 2008-2015 8
Table 2: Orthobiologics Market, Sweden, Revenue ($m), USD Constant, Forecast, 2015-2022 10
Table 3: Bone Grafts and Substitutes Market, Sweden, Revenue ($m), USD Constant, Historic, 2008-2015 12
Table 4: Bone Grafts and Substitutes Market, Sweden, Revenue ($m), USD Constant, Forecast, 2015-2022 14
Table 5: Orthobiologics Market, Sweden, Volume (Units), Historic, 2008-2015 16
Table 6: Orthobiologics Market, Sweden, Volume (Units), Forecast, 2015-2022 18
Table 7: Bone Grafts and Substitutes Market, Sweden, Volume (Units), Historic, 2008-2015 20
Table 8: Bone Grafts and Substitutes Market, Sweden, Volume (Units), Forecast, 2015-2022 22
Table 9: Orthobiologics Market, Sweden, Average Price ($), Historic, 2008-2015 23
Table 10: Orthobiologics Market, Sweden, Average Price ($), Forecast, 2015-2022 24
Table 11: Orthobiologics Market, Sweden, Average Price ($) Historic, 2008-2015 25
Table 12: Orthobiologics Market, Sweden, Average Price ($), Forecast, 2015-2022 26
Table 13: Orthobiologics Market, Sweden, Distribution Share by Revenue ($m), USD Constant, 2008-2022 27
Table 14: Orthobiologics Market, Sweden, Company Share by Revenue ($m), USD Constant, 2015 29
Table 15: Orthobiologics Market Pipeline Products 35
Table 16: Doxa to Raise USD0.72 Million in Public Offering of Shares 38

1.2 List of Figures
Figure 1: Orthobiologics Market, Sweden, Revenue ($m), USD Constant, Historic, 2008-2015 7
Figure 2: Orthobiologics Market, Sweden, Revenue ($m), USD Constant, Forecast, 2015-2022 9
Figure 3: Bone Grafts and Substitutes Market, Sweden, Revenue ($m), USD Constant, Historic, 2008-2015 11
Figure 4: Bone Grafts and Substitutes Market, Sweden, Revenue ($m), USD Constant, Forecast, 2015-2022 13
Figure 5: Orthobiologics Market, Sweden, Volume (Units), Historic, 2008-2015 15
Figure 6: Orthobiologics Market, Sweden, Volume (Units), Forecast, 2015-2022 17
Figure 7: Bone Grafts and Substitutes Market, Sweden, Volume (Units), Historic, 2008-2015 19
Figure 8: Bone Grafts and Substitutes Market, Sweden, Volume (Units), Forecast, 2015-2022 21
Figure 9: Orthobiologics Market, Sweden, Company Share (%) 2015 28

【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチ(株)はその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチ(株)が翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

★調査レポート[スウェーデンのオーソバイオロジクス市場見通し]についてメールでお問い合わせはこちら


※世界の市場調査資料 総合販売サイトMarketReport.jpはH&Iグローバルリサーチ株式会社が運営しております。海外進出、グローバル事業戦略策定、新規事業機会の発掘、競合他社の動向把握などに必要な情報やインサイトをお客様にご提供しております。H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。
※当サイトでは2016年12月09日現在 219,203 件の調査レポートを取り扱っております。当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。

◆H&Iグローバルリサーチのお客様(例)◆